Literature DB >> 34110396

Bilateral Chilblain-like Lesions of the Toes Characterized by Microvascular Remodeling in Adolescents During the COVID-19 Pandemic.

Valentina Discepolo1, Andrea Catzola1, Luca Pierri1, Massimo Mascolo2, Francesca Della Casa3, Maria Vastarella4, Grace Smith5, Antonio Travaglino2, Alessandra Punziano3, Paola Nappa4, Stefania Staibano2, Eugenia Bruzzese1, Gabriella Fabbrocini4, Alfredo Guarino1, Maria Alessio1.   

Abstract

Importance: Chilblain-like lesions have been one of the most frequently described cutaneous manifestations during the COVID-19 pandemic. Their etiopathogenesis, including the role of SARS-CoV-2, remains elusive. Objective: To examine the association of chilblain-like lesions with SARS-CoV-2 infection. Design, Setting, and Participants: This prospective case series enrolled 17 adolescents who presented with chilblain-like lesions from April 1 to June 30, 2020, at a tertiary referral academic hospital in Italy. Main Outcomes and Measures: Macroscopic (clinical and dermoscopic) and microscopic (histopathologic) analysis contributed to a thorough understanding of the lesions. Nasopharyngeal swab, serologic testing, and in situ hybridization of the skin biopsy specimens were performed to test for SARS-CoV-2 infection. Laboratory tests explored signs of systemic inflammation or thrombophilia. Structural changes in peripheral microcirculation were investigated by capillaroscopy.
Results: Of the 17 adolescents (9 [52.9%] male; median [interquartile range] age, 13.2 [12.5-14.3] years) enrolled during the first wave of the COVID-19 pandemic, 16 (94.1%) had bilaterally localized distal erythematous or cyanotic lesions. A triad of red dots (16 [100%]), white rosettes (11 [68.8%]), and white streaks (10 [62.5%]) characterized the dermoscopic picture. Histologic analysis revealed a remodeling of the dermal blood vessels with a lobular arrangement, wall thickening, and a mild perivascular lymphocytic infiltrate. SARS-CoV-2 infection was excluded by molecular and serologic testing. In situ hybridization did not highlight the viral genome in the lesions. Conclusions and Relevance: This study delineated the clinical, histologic, and laboratory features of chilblain-like lesions that emerged during the COVID-19 pandemic, and its findings do not support their association with SARS-CoV-2 infection. The lesions occurred in otherwise healthy adolescents, had a long but benign course to self-resolution, and were characterized by a microvascular remodeling with perivascular lymphocytic infiltrate but no other signs of vasculitis. These results suggest that chilblain-like lesions do not imply a concomitant SARS-CoV-2 infection. Ongoing studies will help clarify the etiopathogenic mechanisms.

Entities:  

Year:  2021        PMID: 34110396     DOI: 10.1001/jamanetworkopen.2021.11369

Source DB:  PubMed          Journal:  JAMA Netw Open        ISSN: 2574-3805


  8 in total

Review 1.  Chilblains-Like Lesions in Pediatric Patients: A Review of Their Epidemiology, Etiology, Outcomes, and Treatment.

Authors:  Jessica Fennell; Karen Onel
Journal:  Front Pediatr       Date:  2022-06-23       Impact factor: 3.569

Review 2.  Nails and COVID-19 - A comprehensive review of clinical findings and treatment.

Authors:  Uwe Wollina; Jean Kanitakis; Robert Baran
Journal:  Dermatol Ther       Date:  2021-08-22       Impact factor: 3.858

Review 3.  COVID-19 associated pediatric vasculitis: A systematic review and detailed analysis of the pathogenesis.

Authors:  Ezgi Deniz Batu; Seher Sener; Seza Ozen
Journal:  Semin Arthritis Rheum       Date:  2022-06-09       Impact factor: 5.431

4.  Evolution of incidence of chilblain-like lesions in children during the first year of COVID-19 pandemic.

Authors:  Marta Bascuas-Arribas; David Andina-Martinez; Juan Añon-Hidalgo; Jose Antonio Alonso-Cadenas; Angela Hernandez-Martin; Nuria Lamagrande-Casanova; Lucero Noguero-Morel; Ana Mateos-Mayo; Isabel Colmenero-Blanco; Antonio Torrelo
Journal:  Pediatr Dermatol       Date:  2022-02-07       Impact factor: 1.997

5.  Paucity of cutaneous manifestations of COVID-19 among inpatients at a referral hospital in India.

Authors:  Kabir Sardana; Surabhi Sinha; Amlendu Yadav; Desh Deepak; Sanjeet Panesar; Sinu Rose Mathachan
Journal:  JAAD Int       Date:  2022-01-12

6.  Lack of association between pandemic chilblains and SARS-CoV-2 infection.

Authors:  Jeff R Gehlhausen; Alicia J Little; Christine J Ko; Marc Emmenegger; Carolina Lucas; Patrick Wong; Jon Klein; Peiwen Lu; Tianyang Mao; Jillian Jaycox; Eric Wang; Nelson Ugwu; Cate Muenker; Dilgash Mekael; Rhonda Q Klein; Robert Patrignelli; Richard Antaya; Jennifer McNiff; William Damsky; Kathy Kamath; John Shon; Aaron M Ring; Inci Yildirim; Saad Omer; Albert I Ko; Adriano Aguzzi; Akiko Iwasaki
Journal:  Proc Natl Acad Sci U S A       Date:  2022-03-01       Impact factor: 11.205

Review 7.  "COVID toes": A true viral phenomenon or a diagnosis without a leg to stand on?

Authors:  Jia C Gao; Alisen Huang; Ankuri Desai; Bijan Safai; Shoshana Marmon
Journal:  JAAD Int       Date:  2022-06-19

Review 8.  The potential role of ischaemia-reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and therapeutic implications.

Authors:  Douglas B Kell; Etheresia Pretorius
Journal:  Biochem J       Date:  2022-08-31       Impact factor: 3.766

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.